-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q4 2024.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$7.63M, a 87.5% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$128M, a 46.7% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$128M, a 46.7% increase from 2023.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2023 was -$241M, a 20.1% increase from 2022.
- Arcutis Biotherapeutics, Inc. annual Operating Income (Loss) for 2022 was -$302M, a 46% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)